Clinical Trial Update: The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating melatonin for depression, anxiety, circadian and sleep disturbances in patients after acute coronary syndrome has completed phases 2 a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Major Depressive Disorder

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Zealand University Hospital | Conditions: Depression, Acute Coronary Syndrome | Phase 2, Phase 3 | Status: COMPLETED